The deal is worth $2.8 billion, according to an April 21 news release. The transaction is expected to close in the third quarter of 2022.
Humana intends to use proceeds from the transaction for the repayment of debt and share repurchases, according to the release.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
